ANN ARBOR - Genomenon, an AI-driven genomics company, announced it will collaborate with Alexion, AstraZeneca Rare Disease to make critical information needed for the diagnosis and treatment for a set of rare diseases more readily accessible. The goal of this collaboration is to empower genetic testing labs with the data they need to diagnose patients
ANN-ARBOR—Genomenon, the genetics informatics company, has completed a $5.3 million financing round, company officials announced. The financing will enable the company to expand its commercial operations, which serve genetic testing labs, hospitals, pharmaceutical and biopharma companies. New investors in this round of financing included BroadOak Capital Partners LLC of Bethesda, Md., Green Park & Golf
ANN ARBOR—The Ann Arbor-based genetic research software developer Genomenon Inc. announced the release of version 2.0 of its Mastermind software. The genomic search engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases. Patients, particularly those with
ANN ARBOR - Genomenon, Inc., and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China. Genomenon’s Mastermind is a genomic search engine wiith nearly 3,500 users in over 100 countries, becoming the search engine of choice when researching patient variants
ROYAL OAK - Tember Shea, Portfolio Manager for Invest Detroit Ventures, interviews Mike Klein, CEO of Genomenon, to discuss the latest news coming out of the Ann Arbor-based gene therapy company. Mike Klein To listen, click on https://soundcloud.com/mike-brennan-841872555/e170-genomenon
ANN ARBOR—Genomenon Inc., the Ann Arbor-based genomics research information provider, has announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big data and machine learning data warehouse, for use in genomic applications. The
ANN ARBOR — Genomenon announced that it has completed a $2.5 million equity financing round. Company officials said the financing will expand Genomenon’s commercial reach with clinical diagnostic labs, biotech, and pharmaceutical companies. Genomenon connects patient DNA with the evidence in scientific literature to help doctors provide faster and better treatment decisions for patients with
ANN ARBOR - Genomenon announced today that they will donate Mastermind Genomic Search Engine licenses to the entire team of clinical scientists at Rare Genomics Institute to accelerate their work for patients with rare diseases. Rare Genomics Institute (RG) is a nonprofit organization that has been at the forefront of providing direct support to undiagnosed rare disease patients and
ANN ARBOR - Genomic Data Search company Genomenon has been awarded a Phase 2 Small Business Innovation Research grant by the National Institutes of Health. The amount was not disclosed. The grant will be used to develop and apply machine learning and artificial intelligence algorithms to variant interpretation, the single biggest hurdle in scaling the
ANN ARBOR - Genomenon has struck a co-marketing agreement with Fluidigm Corp. to offer evidence-based genomic panel design services for translational and clinical disease research. Through the Fluidigm-Genomenon joint panel design services offering, researchers will be able to accelerate the design of disease-specific next-generation sequencing, genotyping, and real-time PCR panels for use with highly efficient
